This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Metabolic Disorders
From Proteopedia
| Line 25: | Line 25: | ||
*[[: Category:Metabolic disorder|Metabolic Disorder]] | *[[: Category:Metabolic disorder|Metabolic Disorder]] | ||
<br /> | <br /> | ||
| + | |||
| + | To View FDA Approved Treatments for [[Metabolic Disorders]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]] | ||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | ||
Revision as of 11:45, 29 November 2010
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning Metabolic Disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- HMG-CoA Reductase
- Protective Protein/Cathepsin A (PPCA)
- Protective Protein/Cathepsin A (PPCA) 2
- Thiolase
- Treatment of Gaucher Disease
- Velaglucerase
- Velaglucerase Disulfide Connectivity
To view proteins related to Metabolic Disorders which are Structure Index entries see:
To view automatically seeded indices concerning Metabolic Disorders See:
To View FDA Approved Treatments for Metabolic Disorders See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
